showed a trendp = 0.09
Adenocarcinoma patients with EGFR mutations (29.8%) showed a trend towards shorter TTR ( p = 0.09) and OS ( p = 0.09).
Adenocarcinoma patients with EGFR mutations (29.8%) showed a trend towards shorter TTR ( p = 0.09) and OS ( p = 0.09).